EAM Investors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-30,839
| Closed | -$2.31M | – | 313 |
|
|
2021
Q4 | $2.31M | Buy |
+30,839
| New | +$2.31M | 0.38% | 89 |
|
|
2018
Q3 | – | Sell |
-6,275
| Closed | -$727K | – | 321 |
|
|
2018
Q2 | $727K | Sell |
6,275
-3,863
| -38% | -$448K | 0.11% | 251 |
|
|
2018
Q1 | $820K | Buy |
+10,138
| New | +$820K | 0.14% | 222 |
|
|
2015
Q1 | – | Sell |
-74,915
| Closed | -$3.81M | – | 349 |
|
|
2014
Q4 | $3.81M | Buy |
74,915
+12,147
| +19% | +$618K | 0.53% | 35 |
|
|
2014
Q3 | $2.48M | Sell |
62,768
-1,786
| -3% | -$70.7K | 0.5% | 39 |
|
|
2014
Q2 | $2.78M | Sell |
64,554
-1,292
| -2% | -$55.6K | 0.53% | 28 |
|
|
2014
Q1 | $2.63M | Sell |
65,846
-1,862
| -3% | -$74.5K | 0.47% | 45 |
|
|
2013
Q4 | $1.85M | Buy |
+67,708
| New | +$1.85M | 0.33% | 101 |
|